Research Overview
Origin and classification
Bromantane emerged from Russian research on adaptogenic and actoprotective agents, a category defined less by a shared mechanism than by a shared experimental endpoint: maintenance of work capacity in animals exposed to heat, hypoxia or prolonged exertion. Its adamantane core is the same rigid tricyclic cage found in amantadine and memantine, though the pharmacology reported for bromantane differs substantially from either.
Reported mechanism
Behavioural and neuroimmune studies
Evidence limits and status
- Human data come from small, mostly older studies not indexed to modern reporting standards.
- Bromantane is not approved by the FDA and is not a dietary supplement ingredient.